Calamos Wealth Management LLC Sells 42 Shares of Humana Inc. (NYSE:HUM)

Calamos Wealth Management LLC lowered its position in Humana Inc. (NYSE:HUMFree Report) by 6.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 619 shares of the insurance provider’s stock after selling 42 shares during the quarter. Calamos Wealth Management LLC’s holdings in Humana were worth $283,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in HUM. Rakuten Securities Inc. bought a new position in Humana in the 4th quarter valued at approximately $25,000. Gradient Investments LLC raised its holdings in Humana by 200.0% in the 4th quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock valued at $27,000 after buying an additional 40 shares during the last quarter. Sunbelt Securities Inc. bought a new position in Humana in the 1st quarter valued at approximately $28,000. Nvwm LLC raised its holdings in Humana by 41.0% in the 3rd quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock valued at $42,000 after buying an additional 25 shares during the last quarter. Finally, Turtle Creek Wealth Advisors LLC bought a new position in Humana in the 4th quarter valued at approximately $55,000. Institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

NYSE:HUM opened at $328.33 on Friday. The company has a fifty day moving average of $330.40 and a 200-day moving average of $400.22. Humana Inc. has a twelve month low of $299.23 and a twelve month high of $541.21. The company has a quick ratio of 1.59, a current ratio of 1.59 and a debt-to-equity ratio of 0.63. The firm has a market capitalization of $39.61 billion, a P/E ratio of 16.57, a P/E/G ratio of 1.92 and a beta of 0.45.

Humana (NYSE:HUMGet Free Report) last posted its quarterly earnings results on Thursday, January 25th. The insurance provider reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.76 by ($0.87). Humana had a net margin of 2.34% and a return on equity of 19.44%. The business had revenue of $26.46 billion during the quarter, compared to analyst estimates of $25.47 billion. During the same period in the previous year, the business posted $1.62 EPS. The business’s revenue for the quarter was up 17.9% compared to the same quarter last year. As a group, sell-side analysts anticipate that Humana Inc. will post 16.06 EPS for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.08%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s payout ratio is currently 17.86%.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Argus lowered shares of Humana from a “buy” rating to a “hold” rating in a report on Wednesday, March 13th. Barclays lowered their price target on shares of Humana from $356.00 to $310.00 and set an “equal weight” rating for the company in a report on Tuesday, April 2nd. The Goldman Sachs Group lowered their price target on shares of Humana from $450.00 to $385.00 and set a “buy” rating for the company in a report on Wednesday, April 3rd. Bank of America restated a “neutral” rating and set a $342.00 price target (down previously from $470.00) on shares of Humana in a report on Tuesday, April 2nd. Finally, Truist Financial restated a “hold” rating and set a $550.00 price target on shares of Humana in a report on Friday, January 19th. Eleven analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, Humana currently has a consensus rating of “Hold” and an average target price of $465.42.

Read Our Latest Stock Analysis on HUM

Insider Activity at Humana

In other Humana news, Director Jorge S. Mesquita purchased 545 shares of Humana stock in a transaction that occurred on Tuesday, February 20th. The stock was acquired at an average price of $367.09 per share, with a total value of $200,064.05. Following the transaction, the director now owns 2,578 shares in the company, valued at approximately $946,358.02. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.32% of the stock is currently owned by insiders.

Humana Company Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Stories

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.